COVID-19与阿尔茨海默病的最新研究进展

doi:10.3969/j.issn.1003-9198.2023.05.021

[1] BLAGOSKLONNY M V. From causes of aging to death from COVID-19[J]. Aging: Albany NY, 2020, 12(11):10004-10021.
[2] BEACH S, PRASCHAN N, HOGAN C, et al. Delirium in COVID-19: a case series and exploration of potential mechanisms for central nervous system involvement[J]. Gen Hosp Psychiatry, 2020, 65:47-53.
[3] WANG F Z, KREAM R M, STEFANO G B. Long-term respiratory and neurological sequelae of COVID-19[J]. Med Sci Monit, 2020, 26: e928996.
[4] DE ERAUSQUIN G A, SNYDER H, CARRILLO M, et al. The chronic neuropsychiatric sequelae of COVID-19: the need for a prospective study of viral impact on brain functioning[J]. Alzheimers Dement, 2021, 17(6):1056-1065.
[5] BROWN E E, KUMAR S, RAJJI T K, et al. Anticipating and mitigating the impact of the COVID-19 pandemic on Alzheimer's disease and related dementias[J]. Am J Geriatr Psychiatry, 2020, 28(7):712-721.
[6] ALONSO-LANA S, MARQUIÉ M, RUIZ A, et al. Cognitive and neuropsychiatric manifestations of COVID-19 and effects on elderly individuals with dementia[J]. Front Aging Neurosci, 2020, 12:588872.
[7] HELMS J, KREMER S, MERDJI H, et al. Neurologic features in severe SARS-CoV-2 infection[J]. N Engl J Med,2020, 382(23):2268-2270.
[8] ATKINS J L, MASOLI J A H, DELGADO J, et al. Preexisting comorbidities predicting severe COVID-19 in older adults in the UK biobank community cohort[J]. J Gerontol A Biol Sci Med Sci, 2020, 75(11):2224-2230.
[9] AGNELLO L, PICCOLI T, VIDALI M, et al. Diagnostic accuracy of cerebrospinal fluid biomarkers measured by chemiluminescent enzyme immunoassay for Alzheimer disease diagnosis[J]. Scand J Clin Lab Invest, 2020, 80(4):313-317.
[10] MORADI MAJD R, MAYELI M, RAHMANI F. Pathogenesis and promising therapeutics of Alzheimer disease through eIF2alpha pathway and correspondent kinases[J]. Metab Brain, 2020, 35(8):1241-1250.
[11] SHAMIM D, LASKOWSKI M. Inhibition of inflammation mediated through the tumor necrosis factor α biochemical pathway can lead to favorable outcomes in Alzheimer disease[J]. J Cent Nerv Syst Dis, 2017, 9:117957351772251.
[12] MCKEE C M, COLL R C. NLRP3 inflammasome priming: a riddle wrapped in a mystery inside an enigma[J]. J Leukoc Biol, 2020, 108(3): 937-952.
[13] POLIDORO R B, HAGAN R S, D E SANTIS S R, et al. Overview: systemic inflammatory response derived from lung injury caused by SARS-CoV-2 infection explains severe outcomes in COVID-19[J]. Front Immunol, 2020, 11:1626.
[14] KALOVYRNA N, APOKOTOU O, BOULEKOU S, et al. A 3'UTR modification of the TNF-α mouse gene increases peripheral TNF-α and modulates the Alzheimer-like phenotype in 5XFAD mice[J]. Sci Rep, 2020, 10(1):8670.
[15] FREEMAN T L, SWARTZ T H. Targeting the NLRP3 inflammasome in severe COVID-19[J]. Front Immunol, 2020, 11:1518.
[16] DING H G, DENG Y Y, YANG R Q, et al. Hypercapnia induces IL-1beta overproduction viaactivation of NLRP3 inflammasome: implication in cognitive impairment in hypoxemic adult rats[J]. J Neuroinflammation, 2018, 15(1):4.
[17] MILOVANOVIC J, ARSENIJEVIC A, STOJANOVIC B, et al. Interleukin-17 in chronic inflammatory neurological diseases[J]. Front Immunol, 2020, 11:947.
[18] MUNOZ P, ARDILES A O, PEREZ-ESPINOSA B, et al. Redox modifications in synaptic components as biomarkers of cognitive status, in brain aging and disease[J]. Mech Ageing Dev, 2020, 189:111250.
[19] LABANDEIRA-GARCIA J L, GARRIDO-GIL P, RODRIGUEZ-PALLARES J, et al. Brain renin-angiotensin system and dopaminergic cell vulnerability[J]. Front Neuroanat, 2014, 8:67.
[20] LIM K H, YANG S, KIM S H, et al. Elevation of ACE2 as a SARS-CoV-2 entry receptor gene expression in Alzheimer's disease[J]. J Infect, 2020, 81(3): e33-e34.
[21] POLITI L S, SALSANO E, GRIMALDI M. Magnetic resonance imaging alteration of the brain in a patient with coronavirus disease 2019(COVID-19) and anosmia[J]. JAMA Neurol, 2020, 77(8):1028-1029.
[22] LIMA M, SIOKAS V, ALOIZOU A M, et al. Unraveling the possible routes of SARS-COV-2 invasion into the central nervous system[J]. Curr Treat Options Neurol, 2020, 22(11):37.
[23] WANG H L, TANG X J, FAN H, et al. Potential mechanisms of hemorrhagic stroke in elderly COVID-19 patients[J]. Aging:Albany NY, 2020, 12(11):10022-10034.
[24] DELGADO-ROCHE L, MESTA F. Oxidative stress as key player in severe acute respiratory syndrome coronavirus(SARS-CoV)infection[J]. Arch Med Res, 2020, 51(5):384-387.
[25] PANFOLI I. Potential role of endothelial cell surface ectopic redox complexes in COVID-19 disease pathogenesis[J]. Clin Med:Lond, 2020, 20(5):e146-e147.
[26] NASI A, MCARDLE S, GAUDERNACK G, et al. Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic intervention[J]. Toxicol Rep, 2020, 7:768-771.
[27] HARDAS S S, SULTANA R, CLARK A M, et al. Oxidative modification of lipoic acid by HNE in Alzheimer disease brain[J]. Redox Biol, 2013, 1(1):80-85.
[28] BOSTANCIKLIOGLU M. Severe acute respiratory syndrome coronavirus 2 is penetrating to dementia research[J]. Curr Neurovasc Res, 2020, 17(4):342-343.
[29] ENNERFELT H E, LUKENS J R. The role of innate immunity in Alzheimer's disease[J]. Immunol Rev, 2020, 297(1):225-246.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 12

Metrics

Recommended 10

[1]	SUN Li, YIN Weihong, JING Jun, QIAN Xiali. Effects of intraoperative subanesthetic dose of esketamine on early postoperative cognitive dysfunction in elderly patients undergoing spinal surgery [J]. Practical Geriatrics, 2024, 38(10): 1039-1043.
[2]	. [J]. Practical Geriatrics, 2023, 37(12): 1249-1254.
[3]	. [J]. Practical Geriatrics, 2023, 37(10): 984-988.
[4]	. [J]. Practical Geriatrics, 2023, 37(10): 1041-1043.
[5]	. [J]. Practical Geriatrics, 2023, 37(10): 1059-1063.
[6]	. [J]. Practical Geriatrics, 2023, 37(9): 869-872.
[7]	WANG Min, GUO Wen-jun, TANG Zhong-quan, ZHAO Xiao-min, OU Ting, LI Yun-tao. Association between hearing impairment and Alzheimer's disease: a Meta-analysis [J]. Practical Geriatrics, 2023, 37(9): 915-919.
[8]	. [J]. Practical Geriatrics, 2023, 37(8): 757-760.
[9]	. [J]. Practical Geriatrics, 2023, 37(4): 335-338.
[10]	. [J]. Practical Geriatrics, 2023, 37(3): 234-237.
[11]	GUO Xiao-juan, LIU Jie, WANG Jin, LU Wen-hui, GAO Ling, QU Qiu-min. Investigation and analysis of influencing factors of the medication adherence in patients with Alzheimer’s disease in Xi’an [J]. Practical Geriatrics, 2023, 37(1): 47-50.
[12]	YE Niansi, HU Hui, DENG Bei, LIU Xueting, ZHOU Shi, LI Yucan, WANG Xiaomeng. Current situation and influencing factors of oral health-related quality of life in elderly with mild cognitive impairment [J]. Practical Geriatrics, 2024, 38(7): 674-678.